Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Protein Sciences Corp.
DescriptionRecombinant neuraminidase (rNA) to be added to a vaccine formulation
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationInfluenza virus
Indication DetailsVaccinate against Influenza virus
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today